Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-03-010967
Filing Date
2003-03-28
Accepted
2003-03-28 17:25:09
Documents
10
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2106556z10-k.htm 10-K 755875
3 EX-3.1 a2106556zex-3_1.htm EX-3.1 92548
4 EX-10.2 a2106556zex-10_2.htm EX-10.2 301892
5 EX-10.4 a2106556zex-10_4.htm EX-10.4 45023
6 EX-23.1 a2106556zex-23_1.htm EX-23.1 2539
7 EXHIBIT 99.1 a2106556zex-99_1.htm EX-99.1 3207
8 EXHIBIT 99.2 a2106556zex-99_2.htm EX-99.2 3144
9 G862627.JPG g862627.jpg GRAPHIC 20251
10 G872179.JPG g872179.jpg GRAPHIC 35407
11 G884059.JPG g884059.jpg GRAPHIC 28219
  Complete submission text file 0001047469-03-010967.txt   1290605
Mailing Address 6701 KAISER DRIVE FREMONT CA 94555
Business Address 6701 KAISER DRIVE FREMONT CA 94555 5106086500
ABGENIX INC (Filer) CIK: 0001052837 (see all company filings)

EIN.: 943248826 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24207 | Film No.: 03626386
SIC: 2836 Biological Products, (No Diagnostic Substances)